Guy Toner - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Papers authored by Guy Toner

This paper was not found in any repository, but could be made available legally by the author.

2007 Ian D. Davis, Guy Toner

ORCID

, Adam Broad, Louise M. Campano, Mark Rosenthal

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Guy C. Toner

ORCID

The Challenge of Poor-Prognosis Germ Cell Tumors

Upload

This paper was not found in any repository, but could be made available legally by the author.

2006 D. Goldstein, S. P. Ackland, D. R. Bell, I. N. Olver, I. D. Davis, M. A. Rosenthal, G. C. Toner

ORCID

, M. C. Pinel, M. Byrne

Phase II study of vinflunine in patients with metastatic renal cell carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2005 Altay O. Altuntas, John Slavin, Peter J. Smith, Stephen M. Schlict, Gerard J. Powell, Sam Ngan, Guy Toner

ORCID

, Peter F. M. Choong

Accuracy of Computed Tomography Guided Core Needle Biopsy of Musculoskeletal Tumours

Upload

This paper is made freely available by the publisher.

Michael J. Millward, Anthony Joshua, Rick Kefford

ORCID

, Steinar Aamdal, Damien Thomson, Peter Hersey, Guy Toner

ORCID

, Kevin Lynch

Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

2004 Guy C. Toner

ORCID

Early Identification of Therapeutic Failure in Nonseminomatous Germ Cell Tumors by Assessing Serum Tumor Marker Decline During Chemotherapy: Still Not Ready for Routine Clinical Use

Upload

This paper is made freely available by the publisher.

H. Miles Prince, Paul J. Simmons, Genevieve Whitty, Dominic P. Wall, Lesley Barber, Guy C. Toner

ORCID

, John F. Seymour, Gary Richardson, Robert Mrongovius, David N. Haylock

Improved haematopoietic recovery following transplantation with ex vivo‐expanded mobilized blood cells*

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Alyssa M. Morimoto, Nguyen Tan, Kristina West, Grant McArthur, Guy C. Toner

ORCID

, William C. Manning, Beverly D. Smolich, Julie M. Cherrington

Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

2003 P. F. M. Choong, I. Nizam, S. Y. K. Ngan, S. Schlict, G. Powell, J. Slavin, P. Smith, G. Toner

ORCID

, R. Hicks

Thallium-201 scintigraphy–a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?

Upload

This paper was not found in any repository, but could be made available legally by the author.

R. Jennens, D. Rischin, K. Yuen, G. Toner

ORCID

, M. Millward

Comparison of neutropenia in a randomized, crossover trial of 3-, 6-, and 24-h infusions of paclitaxel

Upload

This paper was not found in any repository, but could be made available legally by the author.

2002 Guy C. Toner

ORCID

, Mark Frydenberg

Poor prognosis germ-cell tumors: An unresolved challenge

Upload

This paper was not found in any repository, but could be made available legally by the author.

Michael Jefford, Guy C. Toner

ORCID

, Jennifer G. Smith, Samuel Y. K. Ngan, Danny Rischin, Michael J. Guiney

Phase II Trial of Continuous Infusion Carboplatin, 5-Fluorouracil, and Radiotherapy for Localized Cancer of the Esophagus:

Upload

This paper was not found in any repository, but could be made available legally by the author.

H. M. Prince, D. Wall, D. Rischin, G. C. Toner

ORCID

, J. F. Seymour, D. Blakey, D. Haylock, P. Simmons, M. Wolf, E. H. Januszewicz, D. Westerman, G. Richardson, J. Scarlett, P. Briggs

CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy

Upload

This paper was not found in any repository, but could be made available legally by the author.

H. M. Prince, J. Bashford, D. Wall, D. Rischin, N. Parker, G. C. Toner

ORCID

, J. F. Seymour, D. Blakey, D. Haylock, P. Simmons, P. Francis, M. Wolf, E. H. Januszewicz, G. Richardson, J. Scarlett and 1 other authors

Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy

Upload

This paper is made freely available by the publisher.

R. Blum, J. F. Seymour, G. Toner

ORCID

Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment

Download from academic.oup.com

This paper was not found in any repository, but could be made available legally by the author.

2001 Guy C. Toner

ORCID

Three and four cycles of bleomycin, etoposide and cisplatinare equivalent in the treatment of good prognosis germ cell cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Gc C. Toner

ORCID

, Mr R. Stockler, Mj J. Boyer, M. Jones, Db B. Thomson, Vj J. Harvey, In N. Olver, H. Dhillon, A. McMullen, Vj J. Gebski, Ja A. Levi, Rj J. Simes

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial

Upload

This paper is made freely available by the publisher.

Guy C. Toner

ORCID

, Greg J. Neerhut, Max A. Schwarz, Vicky J. Thursfield, Thomas F. Sandeman, Graham G. Giles, Ross M. Snow

The management of testicular cancer in Victoria, 1988-1993

Download from onlinelibrary.wiley.com

Distributing this paper is prohibited by the publisher

Mark A. Rosenthal, David Thomas, Ian Davis, Guy Toner

ORCID

, Naeem Noordin, John Zalcberg

ORCID

Pilot Study of Oral Eniluracil/5-FU in the Palliation of Hormone-Refractory Prostate Cancer

Upload

This paper is made freely available by the publisher.

2000 Hm M. Prince, D. Rischin, Gc C. Toner

ORCID

, Jf F. Seymour, D. Blakey, P. Gates, S. Eerhard, P. Chapple, M. Quinn, M. Brettell, S. Juneja, M. Wolf, Eh H. Januszewicz, G. Richardson, J. Scarlett and 1 other authors

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study

Download from www.nature.com

Missing publications? Search for publications with a matching author name.